Search Results 2321-2330 of 17073 for x.gd.cn

  1. Bone cancer - Doctors and departments - Mayo Clinic

    There are no doctors whose last name begins with the letter X X; There are no doctors whose last name begins with the letter Y Y; There are no doctors whose ...

  2. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Displaying 1-3 out of 3 doctors available ; Elizabeth Yan, M.D.. Radiation Oncologist. Rochester, MN ; Fan Yang, M.D.. Radiation Oncologist. Phoenix, AZ ; Linda X.

  3. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  4. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  5. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  6. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  7. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  8. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    This study is to evaluate the safety, efficacy and clinical benefit of BGB-3111 vs ibrutinib in subjects with MYD88 Mutation Waldenström's Macroglobulinemia.

  9. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

    Total bilirubin ≤ 1.5 x ULN OR direct bilirubin ≤ ULN for patients with total bilirubin levels > 1.5 x ULN (performed within 14 days prior to registration).

  10. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression - Mayo Clinic

    The purpose of this study is to obtain an estimate of the biochemical response rate as determined by CA125 response using the Gynecologic Cancer Intergroup ( ...